In this sense, the immunohistochemical assessment of podoplanin could be useful as a predictive marker for the malignant transformation of OPMD, opening a window of opportunity in those patients showing protein overexpression. The gene discussed is PDPN; the disease is oculopharyngeal muscular dystrophy.